Design a Brain Experiment Competition for US High School Students

The Dana Foundation
United States
Monday, September 12, 2016 - Wednesday, January 11, 2017
We’re challenging U.S. high school students to use their knowledge of the brain to design an original brain experiment for a chance to win prizes and be featured on our website. Students need only design the experiment, not complete it. Submissions are due by January 11, 2017. Read the competition guidelines for more details.

Academy of Neuroscience for Architecture 2016: BridgeSYNAPSES

Academy of Neuroscience for Architecture
La Jolla, CA
Thursday, September 22, 2016 - Saturday, September 24, 2016
The ANFA Conference will explore, from a scientific basis, the range of human experiences with elements of architecture, through a collaboration between architects and neuroscientists. We invite neuroscientists, architects and other professionals to present research and research-based design that will illuminate the neuroscience of the experience of architecture and design of the built environment, as well as the use of insights from neuroscience to develop new approaches to the design of intelligent buildings.

Free Webinar: Advances in the Neurobiology of Mental Illness

The New York Academy of Sciences
New York, NY
Friday, October 07, 2016
This symposium will provide a neutral forum for scientists, physicians, clinicians, other allied healthcare providers, policy makers, and patients across a range of scientific, clinical, industry, and government sectors to explore new scientific understanding of the neurobiology (including genetics, neurocircuitry, and neuroimmune mechanisms) of a range of mental illnesses. Plenary presentations will focus on schizophrenia, major depression, eating disorders, and childhood-onset psychiatric disorders such as autism. In addition to exploring the basic science underlying these illnesses, the symposium will also explore avenues for translating the basic science into treatments, new tools and technologies, and innovative ways to provide overall optimal care for this patient population.

Technology, the Brain, and Audience Expectation: Vying for Attention in Generation Elsewhere

DeVos Institute of Arts Management
Washington, DC
Monday, October 17, 2016
This debate explores "mind change"—a concept pioneered by neuroscientist Susan Greenfield to assess how digital technology is altering the human brain—and how this shapes audiences' interaction with the performing and visual arts. Baroness Greenfield will be joined by thought leaders at the intersection of the tech and cultural sectors, who will be announced in the coming weeks.

Emerging Paradigms in Drug Discovery & Chemical Biology

The New York Academy of Sciences
New York, NY
Tuesday, October 25, 2016
Chemical Biology is changing the face of drug discovery. Over the past decade, chemistry based approaches have facilitated unprecedented advances in our understanding of cell biology and animal physiology, and have proven highly useful for drug discovery, demonstrating success not only in target and mechanism identification, but also in target validation and off-target identification. This symposium will highlight recent advances in on-target and off-target identification of drug-protein interactions in physiologically relevant systems, and will feature talks on the ubiquitin proteasome system, GPCRs, protein lipidation mechanisms, neurobiology, and cancer.

International Neuroethics Society 2016 Annual Meeting

International Neuroethics Society
San Diego, CA
Thursday, November 10, 2016 - Friday, November 11, 2016
In addition to featured panels by leaders in the field, a poster session, and numerous networking opportunities, this year’s meeting will also include an International Ambassador Session and competitively selected, member-led presentations and panel discussions. View the meeting program for a complete schedule of events and speakers. Register before September 15 for discounted rates.

Alzheimer's Disease as a Neurovascular Inflammatory Disorder

The New York Academy of Sciences
New York, NY
Tuesday, December 06, 2016
Alzheimer’s disease (AD) constitutes a significant socioeconomic burden, which will only continue to increase as the global population ages. Significant headway into elucidating disease mechanisms has been made, however this progress has not translated into effective strategies for preventing, treating, or curing this crippling disorder. Emerging research suggests a strong link between brain vascular dysfunction and AD. However, despite mounting evidence for vascular pathology in AD, its role in etiology is hotly debated. As a result, there is a clear need to map the molecular and cellular mechanisms that link vascular disease and AD. This symposium will highlight basic research and clinical science elucidating the mechanisms underlying vascular contributions to cognitive impairment and dementia (VCID).